Abstract
Objectives: To assess and understand the awareness and experience of brain tumour (BT) patients in discussing Advance Care Planning (ACP), to identify main symptoms experienced, physical and functional status perceived quality of life, and level of coping. Methods: A prospective cohort study with an initial open-ended questionnaire followed by semi-structured interview questions regarding ACP with 18 patients diagnosed with BT (WHO Grade I-IV, metastatic BT) in hospital and community. Standardized assessments measured coping strategies, and quality of life (QoL). Interview transcripts regarding ACP discussions were analyzed, coded and interpreted using qualitative analytic techniques for thematic analyses. Results: Participants' mean age was 51 years (range 22-65 years), female (61%); median time since BT diagnosis was 1.5 years and just over half (56%) had glioblastoma multiforme (GBM). Fatigue was the most common symptom reported by 83% of participants. Overall, participants indicated good QoL and used more problem-focused coping strategies including ‘acceptance’ and ‘positive reframing’. Thematic analyses indicated that participants had limited awareness and understanding of ACP, variable views on appropriate timing of ACP discussions and change of decisions over illness trajectory. Most felt able to discuss ACP and preferred dedicated sessions by a trained health professional. Conclusion: This study highlights the importance of providing timely information regarding ACP to BT patients during the course of their disease. Established ACP discussions have an important role in enhancing patient autonomy and to guide delivery of end-of-life care. The demonstrated low uptake of ACP in this pilot study shows need for improved awareness in clinical practice for timely ACP discussions and multifaceted interventions system-wide in implementing ACP.
Highlights
Primary brain tumours (BT) are a diverse group of neoplasms, affecting approximately seven persons per 100,000 population annually, worldwide [1]
This study was approved by the Human Research and Ethics Committee (HREC) of the Royal Melbourne Hospital (RMH), a tertiary facility in Victoria, Australia (HREC 2014.221)
Just over half (56%) had glioblastoma multiforme (GBM) and 2 participants had metastatic BT
Summary
Primary brain tumours (BT) are a diverse group of neoplasms, affecting approximately seven persons per 100,000 population annually, worldwide [1]. In Australia, there are more than 1200 deaths from malignant and benign BT annually. 50% of primary BT are gliomas and half of these are glioblastoma multiforme (GBM) [1, 2], which are aggressive and fatal. BT causes other disabilities such as fatigue, difficulties with mobility and self-care, behavioral dysfunction, psychological problems, social and vocational issues. It often disrupts family life, work and recreation, with implications for caregivers, health and social services. Caregiver strain can involve role reversal within family, physical and financial strain, and reduced quality of life (QoL) [6]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
